Core Viewpoint - The company has released its third-quarter financial report for 2025, highlighting significant changes in financial metrics and the election of a new board of directors [12][8]. Financial Data Summary - The company reported a decrease in long-term receivables by 6.19 million yuan, a decline of 32.54%, primarily due to the recovery of post-sale rental deposits [5]. - Long-term prepaid expenses increased by 5.76 million yuan, up 43.86%, attributed to the rise in consulting and advisory fees [5]. - Other non-current assets rose by 107.48 million yuan, an increase of 78.59%, due to increased prepayments for equity investments [5]. - Long-term borrowings increased by 279.47 million yuan, a rise of 34.84%, as the company took out new long-term loans after repaying short-term borrowings [5]. - Long-term payables decreased by 59.06 million yuan, down 57.67%, due to the payment of payables due within one year [5]. Profit and Loss Summary - Financial expenses decreased by 27.38 million yuan, a decline of 31.09%, mainly due to lower interest expenses on bank loans [6]. - Investment income fell by 45.85 million yuan, a decrease of 80.05%, due to dividends received from a subsidiary [6]. - Credit impairment losses decreased by 8.16 million yuan, a decline of 438.13%, as the company reversed bad debt provisions [6]. - Operating income decreased by 2.06 million yuan, down 37.14%, due to a reduction in non-recurring income [6]. - Operating expenses decreased by 42.69 million yuan, a decline of 83.93%, primarily due to compensation payments made by a subsidiary [6]. Shareholder Information - The company held its second extraordinary general meeting of 2025 on July 30, where the election of the ninth board of directors was approved [8]. - The new board consists of 11 members, with a term of three years starting from the date of approval [8]. Audit Firm Appointment - The company plans to reappoint Lixin Certified Public Accountants as the auditor for the 2025 financial report, which complies with relevant regulations [22][23]. - Lixin has a strong track record, with 2,498 registered accountants and a revenue of 4.748 billion yuan in 2024 [24][25]. - The company also intends to appoint Zhongshunzhonghuan Certified Public Accountants for internal control audits for 2025, which has a solid reputation and experience in the industry [35][36]. Upcoming Shareholder Meeting - The company will hold its third extraordinary general meeting on November 11, 2025, to discuss various proposals, including the reappointment of audit firms [52][53].

Core Insights - The company reported a slight decrease in revenue for the first three quarters of 2025, amounting to 2,568,747,304.73 yuan, which represents a year-on-year decline of 0.03% [1] - However, the net profit attributable to shareholders increased significantly by 20.64%, reaching 135,082,405.18 yuan compared to the same period last year [1] Financial Performance - Revenue for the first three quarters of 2025: 2,568,747,304.73 yuan [1] - Year-on-year revenue change: -0.03% [1] - Net profit attributable to shareholders: 135,082,405.18 yuan [1] - Year-on-year net profit change: +20.64% [1]

Core Viewpoint - Kailong Co., Ltd. (002783.SZ) reported a slight decline in revenue for the first three quarters of 2025, while net profit showed significant growth [1] Financial Performance - The company achieved an operating income of 2.569 billion yuan, representing a year-on-year decrease of 0.03% [1] - Net profit attributable to shareholders reached 135 million yuan, reflecting a year-on-year increase of 20.64% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 119 million yuan, marking a year-on-year growth of 29.82% [1]

Group 1 - Kailong Co., Ltd. reported a revenue of approximately 2.569 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 0.03% [1] - The net profit attributable to shareholders of the listed company was approximately 135 million yuan, showing a year-on-year increase of 20.64% [1] - The basic earnings per share increased by 12.5% to 0.27 yuan [1] Group 2 - As of the report, Kailong Co., Ltd. has a market capitalization of 5.1 billion yuan [2] - The Chinese innovative drug sector has generated 80 billion US dollars in overseas licensing this year [2] - The secondary market for biomedicine is experiencing a boom, while the primary market is facing challenges in fundraising [2]

Group 1 - The company Kailong Co., Ltd. (SZ 002783) announced on October 24 that its ninth board meeting was held to discuss the proposal to reappoint Lixin Certified Public Accountants for the 2025 financial report audit [1] - For the first half of 2025, the revenue composition of Kailong Co., Ltd. is as follows: 34.92% from civil explosive materials, 28.7% from blasting services, 26.74% from ammonium nitrate and compound fertilizers, and 5.83% from other sources, with nano calcium carbonate and stone accounting for 3.81% [1] - As of the report date, the market capitalization of Kailong Co., Ltd. is 5.1 billion yuan [1] Group 2 - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a hot secondary market for biomedicine, while the primary market is experiencing a fundraising slowdown [1]

Core Viewpoint - Kailong Co., Ltd. reported a slight decline in revenue for the first three quarters of the year, while net profit showed significant growth, indicating a potential resilience in profitability despite revenue challenges [1] Financial Performance - The company's operating revenue for the first three quarters was 2.569 billion yuan, a year-on-year decrease of 0.03% [1] - Net profit attributable to shareholders reached 135 million yuan, reflecting a year-on-year increase of 20.64% [1] - The net profit excluding non-recurring gains and losses was 119 million yuan, which represents a year-on-year growth of 29.82% [1]

证券代码：002783 证券简称：凯龙股份 公告编号：2025-075 湖北凯龙化工集团股份有限公司 关于拟续聘立信会计师事务所（特殊普通合伙）为公司2025 年度财务报告审计机构的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 湖北凯龙化工集团股份有限公司（以下简称"公司"或"本公司"）拟续聘立 信会计师事务所（特殊普通合伙）（以下简称"立信会计师事务所"或"立信"）为 公司 2025 年度财务报告审计机构。符合财政部、国务院国资委、证监会印发的 《国有企业、上市公司选聘会计师事务所管理办法》（财会〔2023〕4 号）的规 定。 一、拟聘任会计师事务所的基本情况 （一）机构信息 2．投资者保护能力 截至 2024 年末，立信已提取职业风险基金 1.71 亿元，购买的职业保险累计 赔偿限额为 10.50 亿元，相关职业保险能够覆盖因审计失败导致的民事赔偿责任。 | 起 诉 （ | 仲 | 被 诉 （ 被 仲 | 诉讼（仲裁） | 诉讼（仲裁） | 诉讼（仲裁）结果 | | --- | --- | --- | --- | --- | --- | ...

证券代码：002783 证券简称：凯龙股份 公告编号：2025-076 湖北凯龙化工集团股份有限公司 关于拟续聘中审众环会计师事务所（特殊普通合伙）为 公司2025年度内部控制审计机构的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 湖北凯龙化工集团股份有限公司（以下简称"公司"或"凯龙股份"）拟续聘 中审众环会计师事务所（特殊普通合伙）（以下简称"中审众环"）为公司2025 年度内部控制审计机构，符合财政部、国务院国资委、证监会印发的《国有企业、 上市公司选聘会计师事务所管理办法》（财会〔2023〕4 号）的规定。 一、拟聘任内部控制审计机构的基本情况 （一）机构信息 1．基本信息 （1）机构名称：中审众环会计师事务所（特殊普通合伙） （2）成立日期：中审众环始创于1987年，是全国首批取得国家批准具有从 事证券、期货相关业务资格及金融业务审计资格的大型会计师事务所之一。根据 财政部、证监会发布的从事证券服务业务会计师事务所备案名单，中审众环具备 股份有限公司发行股份、债券审计机构的资格。2013年11月，按照国家财政部等 有关要求转制为特 ...

证券代码：002783 证券简称：凯龙股份 公告编号：2025－077 3．本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市 公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有 关规定。 4．会议时间： （1）现场会议时间：2025 年 11 月 11 日 14:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 11 月 11 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互 联网投票系统投票的具体时间为 2025 年 11 月 11 日 9:15 至 15:00 的任意时间。 湖北凯龙化工集团股份有限公司 关于召开2025年第三次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 湖北凯龙化工集团股份有限公司（以下简称"公司"）第九届董事会第三次会 议决定，于2025年11月11日（星期二）14:30召开2025年第三次临时股东会，本 次会议将采用现场书面投 ...

证券代码：002783 证券简称：凯龙股份 公告编号：2025－073 湖北凯龙化工集团股份有限公司 第九届董事会第三次会议决议公告 一、董事会会议召开情况 湖北凯龙化工集团股份有限公司（以下简称"公司"）第九届董事会第三次会 议于2025年10月14日以电话、电子邮件的方式发出会议通知，并于2025年10月24 日以书面审议和通讯表决方式召开，应参加本次会议表决的董事11人，实际参加 本次会议的董事为11人。本次会议的召集、召开和表决程序符合《公司法》和《公 司章程》的有关规定，合法有效。 二、董事会会议审议情况 1．审议通过《公司2025年第三季度报告》 本议案已经公司董事会审计委员会审议通过，并同意提交公司董事会审议。 《公司2025年第三季度报告》具体内容详见同日《证券时报》《中国证券报》 《上海证券报》《证券日报》及巨潮资讯网http://www.cninfo.com.cn。 表决结果：同意11票，反对0票，弃权0票。 2．审议通过《关于拟续聘立信会计师事务所（特殊普通合伙）为公司2025 年度财务报告审计机构的议案》 本议案已经公司董事会审计委员会审议通过，并同意提交公司董事会审议。 本公司及董事 ...